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Abstract
Background: This study aimed to examine the associations of age with the presence of complications and
glycemic control in the Northwest of Iran.
Methods: A total of 649 people with diabetes who were >25 years old and had a caring record in diabetes clinics
in two Northwestern provinces of Iran during 2014–15, were recruited in this cross-sectional study. General
information including demographic, socioeconomic status and lifestyle factors were collected by trained
interviewers. Clinical information was retrieved from clinic's record. Univariate and multivariate logistic regression
were performed to assess the predictors of diabetes outcome of interest as well as to clarify the role of age in
relation to these outcomes.
Results: Compared to the age group of ≤49, the middle age group (50–59) and the older age group (60 years of age
and older) were less likely to report poor glycemic control (OR fully adjusted = 0.49 95% CI: 0.28–0.86 and (OR = 0.44
95% CI: 0.24–0.80), respectively. Additionally, poor glycemic control was associated with income level, disease duration,
hypercholesterolemia, high level of LDL and hypertension. In contrast, age was associated with the highest percentage
of complications. People with duration of >7 years of disease record were 6 times more likely to have complications
(ORadj = 5.98 95% CI: 2.35–15.22).
Conclusion: Although the prevalence of complications was higher among the older diabetic patients, they had a
better glycemic control. The influential factors were variably associated with the two diabetes-related outcomes;
therefore, a more comprehensive risk profiles assessment is needed for glycemic control.
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Background
Diabetes is a global concern driven by both population
growth and ageing [1]. There were 387 million people
with diabetes in 2013 and that is predicted to reach 592
million by 2035. The majority of these people fall
between the ages of 40 and 59, and 80% of them live in
low- and middle-income countries [2].
Diabetes as a chronic disease has a negative impact
on different organs due to the negative effect of hyper-
glycemia and requires ongoing management. There is
evidence that diabetic complications, hospitalization
and mortality are more prevalent among older people
with diabetes [3–6]. In contrast, the relationship between
age and glycemic control has been reported to be
inconclusive. Some studies have reported a high preva-
lence of poor control in the elderly [7], there are studies
which point to no effect of age on metabolic control [8],
to better glycemic control among older people [9–12] and
even point to an inverse relationship between age and
glycemic control [13, 14]. Worse glycemic control and
lipid profile, higher prevalence of obesity and additional
cardiovascular risk factors, remarkable increase in the risk
of cardiovascular disease, higher rate of death from hyper-
glycemic crisis, among young diabetic type 2 patients were
reported by some studies [15–18]. Recent trend analysis
of diabetic complications in the USA showed a decline in
the end- stage renal disease across all age groups from
2000 to 2010, however the age difference for rates of acute
myocardial infarction and stroke has been narrowed, bring
this to the attention that younger adults with diabetes
require more rigorous care and management [19].
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Better glycemic control among older people might be
explained by other factors such as Body Mass Index
(BMI) and disease duration [20, 21]. However, some
studies found an independent role for age after consider-
ation of BMI and disease duration [9, 13]. Therefore, the
aim of this study was to examine age-related associations
with the presence of complications and glycemic control
in people with type 2 diabetes.
We conducted this study in the northwest of Iran:
Ardabil and East Azerbaijan provinces. Almost all the
people living in these areas have Azari-Turkish back-
ground with different sociocultural values influencing
their lifestyle. Diabetes is a major concern in these areas
[22, 23] where not only have previous studies shown
inadequate diabetes care and high prevalence of compli-
cations but relatively poor quality of life among these
people has been referred to as well [24–27].
Methods
A cross-sectional study was conducted in the North-
west of Iran. People with T2DM referring to diabetes
clinics (Imam Khomeini Hospital in Ardabil during
January and May 2014, and Imam Reza and Sina in Ta-
briz during November 2014 to March 2015) were se-
lected through a convenience sampling method. These
centers are referral clinics in these areas in the North-
west of Iran. The study inclusion criteria were: diagno-
sis of T2DM, age ≥25 years of old, having a caring
record in the clinic, at least, for one year, residing
urban regions of the provinces, and not having special
and debilitating diseases (hemophilia and thalassemia).
Exclusion criteria were unwillingness to participate in
the study and having other types of diabetes.
The present study was approved by the Ethics
Committee of Tabriz University of Medical Sciences
(Ethic numbers TBZMED.REC.1392.207 and TBZME-
D.REC.1394.55), and at the beginning of the study,
informed consent was obtained in written forms from
all of the participants.
Measurements
Data was collected using a structured questionnaire by
two trained interviewers. The questionnaire was divided
into two parts. Part one consists of general information
including age, gender, place of residence, marital status,
monthly household income, health insurance, education
level, weight and height. Part two includes clinical
features as such blood pressure, lipid profile, disease
duration. Moreover, complications i.e. neuropathy,
retinopathy, nephropathy and cardiovascular complica-
tions were gathered (Additional file 1). Age was classified
into 3 categories of ≤49, 50–59 and ≥60 years of age. For
the purpose of some analysis, it was integrated into two
categories of <60, ≥60 years old. Some predictors were
drawn from clinic's records such as blood pressure,
BMI, total cholesterol, Fasting Blood Sugar (FBS) and
were defined as: controlled hypertension (systolic
blood pressure <140 mmHg, and diastolic <90 mmHg),
and desirable cholesterol <240 mg/dl, HbA1C <7%,
and FBS < 126 mg/dl, based on the recent American
Diabetes Association recommendation [28]. BMI was
classed into three categories; <25, 25–29.9, and ≥30.
Statistical analysis
Descriptive analyses were used to describe the general
characteristics of the study population. Two diabetes
care outcomes, that is presence of any complication and
glycemic control, based on HbA1C values, were chosen
and described based on a range of predictors of interest.
Then a univariate analysis was performed to assess the
association between age and a list of covariates. Multi-
variable logistic regression models with glycemic control
and presence of complications as the dependent variable
were used to estimate odds ratios (ORs) with 95% confi-
dence intervals (CI). Two models were built: adjusted
for age, sex, and measures of socioeconomic status (edu-
cational attainment and income); and adjusted for age,
sex, measures of socioeconomic status and related clinical
factors (BMI, lipid profile, hypertension, and duration of
disease). In order to analyze the independent association
of the age factor with glycemic control and presence of
complications, the basic analysis was repeated, separately,
with adjustment for each influential predictor. Analysis
was performed using the statistical package for social
science (SPSS) Version 23 and a significance level of 5%
was set prior to the initiation of the study.
Results
A total of 694 people with T2DM were included in this
study. The mean age of the participants was 55.71 (8.99),
about 70% of them were female, 89% married, 47%
illiterate, 20% of them were engaged in paid work, and the
monthly income of 63.3% were reported to be less than
1000,000 Tomans,1 less than 2% of the participants were
smokers, and the majority of them (80%) was overweight/
obese. Approximately, duration of disease among 58.6% of
the patients was more than 7 years; about 50% had, at
least, one complication. 37.5% of participants in the old
age group (≥60) were male whilst it was 26.8% in younger
age group (P < 0.001). Higher percentages of older partici-
pants (59.2%) were illiterate and 75.7% of them had low
level of income which was statistically significant (P <
0.001 & P = 0.003 respectively). The prevalence of hyper-
tension was significantly higher among older age group
than younger adults (63.1% vs. 53.7%, P = 0.019). More-
over, complications were higher among elderly compare
to younger participants (57.1% vs. 45.2%. P = 0.003)
(Table 1). The frequency of complications in this study
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according to the patient’s clinic record were neuropathy
(34.9%), retinopathy (16%), nephropathy (5.9%), stroke
(1.6%) and cardiovascular disease (6.1%).
Table 2 shows the bivariate association between pre-
dictors and both outcomes. Females were more likely
to have complications (P = 0.01), the frequency of
complications was the lowest in the age group of ≤49,
and the highest frequency was in the age group of 60+
(P = 0.001). The frequency of both outcomes was
higher among illiterate people with type 2 diabetes
(P = 0.003 to 0.01). The frequency of complications
and poor glycemic control increased as the disease
duration increased (P < 0.001, P = 0.003, respectively). In-
come, cholesterol level, hypertension, LDL and FBS were
Table 1 Socio-demographic and major risk factors of study
participants by age
Characteristics Younger age (≤59) Older age (≥60) P value
N (%) N (%)
Sex
Male 117 (26.8) 90 (37.5) 0.001
Female 337 (74.2) 150 (62.5)
Education
Illiterate 154 (33.9) 142 (59.2) <0.001
Primary school 172 (37.9) 58 (24.2)
Secondary school
& higher
128 (28.2) 40 (16.7)
Income
Low (<1000,000) 273 (65.0) 171 (75.7) 0.003
Acceptable 147 (35.0) 55 (24.36)
Smoking
Yes 33 (7.3) 26 (12.1) 0.07
No 421 (92.7) 214 (87.9)
BMI
< 25 79 (18.3) 41 (18.4) 0.705
25–29.9 178 (41.2) 83 (40.1)
≥ 30 175 (40.5) 95 (41.5)
Disease Duration (year)
≤ 3 97 (21.5) 38 (15.8) 0.110
4–7 115 (25.4) 46 (19.2)
≥ 7 240 (53.1) 156 (65)
Hypertension
No 196 (46.3) 87 (36.9) 0.019
Yes 227 (53.7) 149 (63.1)
Total Cholesterol
Desirable 365 (92.4) 198 (93.8) 0.317
≥ 240 30 (7.6) 13 (6.2)
HbA1c
< 7 143 (37) 77 (37) 0.99
≥ 7 244 (63) 131 (63)
Complication
No 249 (54.8) 103 (43.9) 0.003
Yes 205 (45.2) 137 (57.1)
Table 2 Prevalence of complication and poor glycemic control
among diabetic patients by socio-demographic and clinical
factors, 2014–2015
Characteristics Complications
N (%)
P values Poor glycemic
control N (%)
P value
Sex
Male 87 (42.0) 0.013 113 (64.2) 0.699
Female 255 (52.4) 262 (62.5)
Age group
≤ 49 59 (37.3) 0.001 88 (70.4) 0.118
50–59 146 (49.3) 156 (59.5)
60+ 137 (57.1) 131 (63.0)
Education
Illiterate 159 (53.7) 0.010 177 (69.7) 0.003
Primary school 117 (50.9) 109 (54.2)
Secondary school
& higher
66 (39.3) 89 (63.6)
Income
Low (<1000,000
Tomansa)
223 (50.2) 0.775 255 (70.2) <0.001
Acceptable 99 (49.0) 92 (46.5)
Duration of disease
≤ 3 years 36 (26.7) <0.001 65 (61.3) 0.003
4–7 66 (41.0) 72 (51.8)
> 7 years 240 (60.6) 238 (68.0)
Total Cholesterol
Desirable 287 (51) 0.572 314 (60.4) <0.001
≥ 240 20 (46.5) 36 (90.0)
Smoking
Yes 23 (39.0) 0.091 35 (62.5) 0.386
No 318 (50.5) 340 (68.6)
BMI
< 25 50 (41.7) 0.067 64 (62.1) 0.273
25–29.9 120 (46.0) 153 (68.0)
≥ 30 144 (53.3) 141 (61.0)
Hypertension
Controlled 139 (49.1) 0.963 138 (55) 0.002
Uncontrolled
(≥140/90)
184 (48.9) 217 (67.6)
LDL
Desirable 114 (54.0) 0.082 92 (47.9) <0.001
≥ 100 60 (44.4) 85 (69.7)
a1 US $ = 3200 Tomans
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only associated with poor glycemic control not with
complications (P < 0.001 to 0.002).
Table 3 shows the results of the univariate and multi-
variate logistic regression analyses. Compared to the age
group of ≤49, the middle age group (50–59) and the older
age group (60 years and older) were less likely to report
poor glycemic control (OR fully adjusted = 0.49 95% CI:
0.28–0.86 and (OR = 0.44 95% CI: 0.24–0.80, respectively).
Table 3 Odds Ratio (95% confidence interval) of socio-demographic and clinical predictors with the presence of complications and
poor glycemic control
Characteristics Poor Glycemic Control Presence of Complications
OR1 (95% CI) OR2 (95% CI) OR3 (95% CI) OR1 (95% CI) OR2 (95% CI) OR3 (95% CI)
Age group
≤ 49 Ref group Ref group Ref group Ref group Ref group Ref group
50–59 0.62 (0.39–0.98) 0.57 (0.35–0.94) 0.49 (0.28–0.86) 1.63 (1.10–2.42) 1.53 (1.00–2.33) 1.13 (0.67–1.90)
≥ 60 0.72 (0.44–1.15) 0.51 (0.30–0.87) 0.44 (0.24–0.80) 2.23 (1.48– 3.37) 2.24 (1.41–3.54) 1.74 (1.00–3.02)
P value 0.119 0.039 0.020 0.001 0.003 0.076
Sex
Male Ref group Ref group Ref group Ref group Ref group Ref group
Female 0.93 (0.65– 1.34) 1.25 (0.82–1.92) 0.73 (0.45–1.18) 1.52 (1.09–2.11) 1.57 (1.08–2.28) 1.15 (0.73 –1.82)
P value 0.699 0.304 0.198 0.013 0.019 0.560
Education
Illiterate 1.32 (0.85 –2.04) 1.07 (0.63 –1.82) 1.20 (0.67 –2.17) 1.79 (1.22 –2.63) 1.39 (0.88–2.20) 1.96 (1.12–3.45)
Primary school 0.68 (0.44 – 1.06) 0.64 (0.39– 1.03) 0.75 (0.44–1.26) 1.60 (1.07 –2.40) 1.58 (1.03–2.42) 1.91 (1.14 –3.20)
Secondary school & higher Ref group Ref group Ref group Ref group Ref group Ref group
P value 0.003 0.037 0.152 0.01 0.114 0.027
Income
Low <1000,000 Tomans 2.72 (1.90–3.89) 2.56 (1.75–3.76) 2.56 (1.68–3.90) 1.05 (0.75–1.46) 1.01 (0.76–1.44) 1.04 (0.68–1.60)
Acceptable Ref group Ref group Ref group Ref group Ref group Ref group
P value <0.001 <0.001 <0.001 0.775 0.976 0.860
Duration of disease
≤ 3 years Ref group Ref group Ref group Ref group Ref group Ref group
4–7 0.68 (0.41–1.13) 0.65 (0.37–1.13) 0.88 (0.48–1.63) 1.91 (1.17–3.13) 1.99 (1.16–3.42) 2.98 (1.54–5.76)
> 7 years 1.34 (0.85–2.10) 1.49 (0.91–2.45) 1.55 (0.90–2.65) 4.23 (2.75–6.51) 4.55 (2.82–7.33) 7.25 (4.00–13.12)
P value 0.004 0.001 0.043 <0.001 <0.001 <0.001
BMI
< 25 Ref group Ref group Ref group Ref group Ref group Ref group
25–29.9 1.30 (0.80–2.11) 1.28 (0.75–2.16) 1.92 (0.85–4.36) 1.19 (0.77–1.84) 1.20 (0.75–1.90) 1.42 (0.83–2.42)
≥ 30 0.96 (0.59–1.54) 089 (0.52–1.52) 1.05 (0.45–2.45) 1.60 (1.04–2.47) 1.42 (0.89–2.27) 1.66 (0.97–2.84)
P value 0.274 0.246 0.118 0.067 0.326 0.181
Total Cholesterol
Desirable Ref group Ref group Ref group Ref group Ref group Ref group
≥ 240 5.90 (2/07 –16.84) 5.95 (1.76–20.14) 4.54 (1.29 –15.94) 0.84 (0.45–1/56) 0.93 (0.45–1.90) 1.30 (0.52–3.22)
P value 0.001 0.004 0.018 0.573 0.840 0.887
Hypertension
Controlled Ref group Ref group Ref group Ref group Ref group Ref group
Uncontrolled 1.71 (1.22–2.40) 1.57 (1.09–2.26) 1.49 (1.00–2.22) 0.99 (0.73–1.35) 1.02 (0.73–1.41) 0.83 (0.56–1.23)
P value 0.002 0.016 0.052 0.963 0.929 0.354
OR1: Crude. OR2: Adjusted for age, gender, education and income. OR3: Adjusted for age, gender, education, income, disease duration, cholesterol, BMI, HTN
OR1: Crude. OR2: Adjusted for age, gender, education and income. OR3: Adjusted for age, gender, education, income, duration of disease, Cholesterol, BMI, HTN,
and FBS
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The poor glycemic control was associated with income
level, those with lower income were 2.6 times (95% CI:
1.68–3.90) more likely to have poor glycemic control
compared with those having higher income. The same as-
sociation holds for disease duration, hypercholesterolemia,
high level of LDL and the hypertension (Table 3).
Relative to the younger age group, the middle age group
(OR crude: 1.63 95% CI 1.10–2.42) and the older people
with diabetes were more likely to report the presence of
complication (OR crude = 2.23 95% CI 1.48 – 3.37). The
associations remained statistically significant after adjust-
ment for socio-demographic factors; however, it was
attenuated after adjustment for all other variables. In fully
adjusted model, the older people with diabetes in the age
group of ≥60 were about 1.7 times more likely to have, at
least, one complication (ORadj =1.74 95% CI: 1.00–3.02).
Among the middle age group, the association was attenu-
ated in fully adjusted model and it shows a reduction and
non-significant results.
Females were more likely to have complications
than their male counterparts (OR crude = 1.52 95%
CI: 1.09–2.11). Nevertheless, the association was at-
tenuated in fully adjusted model and was no longer
significant. Duration of disease was significantly asso-
ciated with the presence of complications. In addition,
people with duration of >7 years of disease were 6
times more likely to have complications (ORadj = 5.98
95% CI: 2.35–15.22). Similarly, the same was the case
with the middle-aged participants. Relative to those
with higher level of education, people with diabetes in
other education categories were about 2 times more
likely to suffer from complications.
As can be seen in Table 4, compared to the age group
of ≤49, complications were more likely to be present in
the middle age group (OR = 1.62 95% CI: 1.09–2.42) and
the same was true with the older age group (OR = 2.37
95% CI: 1.56–3.60). These associates remained signifi-
cant even after the addition of other covariates such as
FBS, BMI, cholesterol, duration of disease and hyperten-
sion. Thus, an independent role of age is suggested. How-
ever, there was not such a pattern for glycemic control.
There was little reduction in the OR for the older age
group in comparison with those in the age group of ≤49
which suggests a better glycemic control in these
participants. It is important to note that these pat-
terns remained the same with little attenuation after
adjustment for different covariates.
Discussion
Of the participants of the study, 57.8% had poor glycemic,
and 52.7% had, at least, one complication. Age, income,
hypertension, duration of disease, hypercholesterolemia
were independent predictors of poor glycemic control.
However, only age, education and disease duration played
an independent role in predicting complications.
Glycemic control was better among the middle and
the older age groups in comparison with the younger
age group where adjustment for other covariates had
little effect on the association. Similarly, some studies re-
ported better glycemic control among older age group
[9, 10, 12, 18]. In contrast, complications increased as
the age increased. This remained significant after adjust-
ment for different covariates. There is evidence that
diabetes complications, hospitalization and mortality are
more prevalent among older people with diabetes [3–6].
Specifically speaking, results of our analysis were similar
to the results of the Korean and Spanish studies i.e. in
spite of a better glycemic control, with the older age group
having the highest percentage of complications [5, 18].
In a Korean study, with a nationally representative sample
of people with diabetes, age was an independent predictor
for hospitalization (ORadj = 1.97 95% CI = 1.28, 3.04) for the
oldest group (ages 70–79) vs. youngest group (ages 40–49))
and a better glycemic control (ORadj = 0.45 95% CI = 0.37,
0.56) for the oldest group vs. youngest group [5]. Barrot-de
la Puente et al reported a better glycaemic control among
Table 4 Changes in Odds Ratio (95% confidence interval) of age for complications and poor glycemic control with introduction of
covariate
Outcome of Interest Sex FBS Hypertension Total cholesterol BMI Duration of diabetes
Glycemic control
≤ 49 Ref group Ref group Ref group Ref group Ref group Ref group
50–59 0.62 (0.39–0.98) 0.73 (0.44–1.19) 0.58 (0.36–0.93) 0.62 (0.39–1.00) 0.60 (0.37–0.96) 0.60 0.38–0.95)
60+ 0.71 (0.44–1.15) 0.77 (0.46–1.29) 0.65 (0.40–1.07) 0.70 (0.43–1.16) 0.73 (0.44–1.20) 0.66 (0.40–1.07)
P value 0.12 0.44 0.08 0.15 0.10 0.087
Complications
≤ 49 Ref group Ref group Ref group Ref group Ref group Ref group
50–59 1.62 (1.09–2.42) 1.50 (1.00–2.25) 1.57 (1.04 – 2.38) 1.79 (1.16 –2.76) 1.42 (0.94–2.13) 1.52 (1.00 –2.29)
60+ 2.37 (1.56–3.60) 2.23 (1.46 –3.40) 2.37 (1.54 – 3.66) 2.67 (1.69–4.20) 2.09 (1.36 –3.22) 2.03 (1.32–3.13)
P value ≤0.001 0.001 <0.001 <0.001 0.003 0.006
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older patients independent of disease duration, BMI and
presence of a CVD [18].
There are some other studies which lend credence to
the same results; the independent role of age in a better
glycemic control [4, 10]. This might be partly explained
by the increased attention paid to the medications of the
older age in order to manage their blood glucose which
suggests the need for improved glycemic management in
younger patients.
Further, we examined the confounding or mediating
role of other covariates in the association between the two
outcomes of interest; complications and poor glycemic
control. Simultaneous adjustment of sex and each covari-
ate resulted in minor changes in the impact of age upon
glycemic control. However, the association between age
and the presence of complications changed a little after
introducing FBS, but large changes in magnitude were
observed for BMI and duration of disease (28 to 34%
reduction in the OR between 60+ vs. ≤49 from 2.37 to
2.09 and 2.03, respectively). Adjustment for total choles-
terol showed positive changes in the magnitude of the
association for both the middle and older age groups (17
to 30%, respectively). In Korean study, only continuity of
care provided a large change in the association between
age and hospitalization [5]. This possibly could be ex-
plained with the difference in the population of the study
and the management of diabetes in our clinics which indi-
cates the need for a better management program for
people with T2DM.
Despite useful findings of the present study, it has
some limitations which need to be addressed, as they
might provide an agenda for future studies. The main
limitation of the present study was applying convenience
sampling method which yields non-representative study
participation. However, incomplete clinic records; per-
sonal identification, address change, death or migration
were the main reasons for using this method. In
addition, the majority of the study participations were
women. Therefore, gender differences could not be
adequately studied in this analysis. As this study was
conducted in governmental clinics, the results might
differ from private sectors reflecting different diabetes
care and management. Finally, using a more rigorous sam-
pling method and inclusion of participants from both gov-
ernmental and private sectors are recommended by the
authors in order to improve the generalizability of findings
in future studies.
Conclusion
According to the results of this study, the older diabetic
patients had a higher percentage of complications
despite displaying a better glycemic control. This might
highlight the complexity of management of diabetes
among older patients. The influential factors were
variably associated with the two diabetes-related out-
comes, providing more comprehensive risk profiles for
glycemic control. Functional capacity and comorbidities
may explain the increased complication among older
diabetic patients despite showing a better glycemic
control and suggests a wider geriatric evaluation.
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